Dr Alison McLennan is an Assistant Professor at Faculty of Business, Government and Law, University of Canberra. Alison is particularly interested in the challenges posed to regulation by emerging technologies, especially biotechnologies. Her PhD investigated regulation of synthetic biology and was awarded in 2014. In 2017, she presented the legal issues relating to synthetic biology at the SBA conference held in Sydney. She has continued to publish work on SynBio regulation and patent law, including for general audiences via The Conversation, and has a new book about synthetic biology law and policy issues coming out in 2018. Alison is interested in how we can not only manage the risks of new technologies, but also maximise their potential benefits. Twitter handle: @asmclennan
We are excited to present synthetic biologist, Dr Karen Weynberg, who is the ECR representative of SBA Executive Board. Karen is a CSIRO Future Science Research Fellow based at University of Queensland.
She completed her PhD in the UK in 2009, uncovering new viruses that infect marine phytoplankton. Her first fellowship, the ARC Super Science Research Fellowship, investigated the role of viruses in coral reefs. Her current fellowship uses synthetic biology to develop phage therapy for addressing bacterial biofilms and antibiotic resistance. Suffice to say that Karen is something of a virus aficionado, and has even given a TedX talk and media interviews to BBC News and ABC News. Twitter handle: @ReefViruses